NIPRO CORP.
Research NIPRO CORP. (5FA) on Bullrun: market cap EUR 1.39B, P/E 21.3, dividend yield 2.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker5FA
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 1.39B
- P/E21.3
- Dividend yield2.0%
- Financial periodFY2026
- RevenueJPY 660.54B
- Revenue growth2.5%
- Net incomeJPY 13.50B
- Free cash flowJPY 54.66B
- Gross margin31.5%
Valuation Snapshot
latest market cap is EUR 1.39B; P/E is 21.3; dividend yield is 2.0%.
Peer valuation comparison
Latest P/E is 21.25x versus a Healthcare sector median of 24.46x (13.1% below).
Latest dividend yield is 1.98% versus a Healthcare sector median of 2.11% (6.2% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 660.54B | JPY 13.50B | JPY 54.66B | 31.5% | 73.36 | JPY 97.84B | JPY 641.05B | JPY 274.12B |
| FY2025 | JPY 644.59B | JPY 5.11B | JPY 68.46B | 29.6% | 27.78 | JPY 106.67B | JPY 636.87B | JPY 252.45B |
| FY2024 | JPY 586.79B | JPY 11.11B | JPY 72.94B | 29.2% | 24.85 | JPY 99.67B | JPY 635.69B | JPY 232.66B |
| FY2023 | JPY 545.20B | JPY 4.57B | JPY 10.40B | 30.0% | 24.85 | JPY 89.68B | JPY 605.93B | JPY 206.32B |
| FY2022 | JPY 494.79B | JPY 13.46B | JPY 68.21B | 30.2% | 77.42 | JPY 95.34B | JPY 564.85B | JPY 185.24B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 1.39B | 21.3 | 2.1% | 0.17 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.17 EUR, yield 2.0%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.1 JPY |
| FY2025 | 0.12 JPY |
| FY2024 | 0.15 JPY |
| FY2023 | 0.1 JPY |
| FY2022 | 0.14 JPY |
About NIPRO CORP.
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NIPRO CORP.'s market cap?
NIPRO CORP.'s market capitalization is EUR 1.39B.
What is NIPRO CORP.'s P/E ratio?
NIPRO CORP.'s price-to-earnings (P/E) ratio is 21.3.
Does NIPRO CORP. pay a dividend?
NIPRO CORP. has a dividend yield of 2.0%.
What does NIPRO CORP. do?
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers.